Schwab K, Smith R, Wager E, et al. - Researchers conducted an observational, prospective cohort study in consecutive patients with nonvalvular atrial fibrillation (NVAF) presenting to the emergency departments (ED) for determining guideline recommended anticoagulation prescribing among these patients, with the goal of closing any treatment gap established. They calculated CHA2DS2-VASc and HAS-BLED scores and employed these scores as predefined criteria to establish guideline-based oral anticoagulant (OAC) compliance in comparing routine care (baseline cohort) vs a multidisciplinary team approach. In the Baseline Cohort (BC) ( n  =  99), discharge on guideline-based OAC therapy was reported in 62.3% of patients with a moderate-high risk of stroke (CHA2DS2-VASc score ≥ 2) vs 87.8% in the Multidisciplinary Team Cohort ( n = 131), a 25.5% overall improvement for apt anticoagulation. This indicates that a significant improvement in the percentage of moderate to high-risk patients that are discharged home with guideline based OAC could be achieved using a multidisciplinary team approach with Transition of Care services for the identification and early intervention of NVAF patients at risk of stroke in the ED.